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VelloreAbstract A frequent cross-sectional study was conducted to determine the patterns of antimicro-
bial resistance in 296 bacterial strains isolated from in-patient faecal samples of Government
Vellore Medical College and Hospital, Vellore. Isolation and identification of bacterial strains were
done using enrichment media, selective media, and biochemical tests. Antimicrobial susceptibility
testing by the disc diffusion method and minimal inhibitory concentration method was conducted
and the strains were subjected to extended spectrum beta-lactamases screening. Antibiotic sensitiv-
ity pattern of Staphylococcus spp. showed oxacillin resistance. Almost all the strains were sensitive
to linezolid, vancomycin, gentamycin and chloramphenicol. In gram negative isolates ciprofloxacin
and tobramycin showed better sensitivity and ceftazidime showed a higher percentage of resistance
by MIC. Out of 250 isolates, Enterobacteriaceae showed positive for 86/250, 82/250 and 94/250 iso-
lates and 3/10, 4/10 and 4/10 non-Enterobacteriaceae isolates were found to be positive for CTX-M
gene, TEM gene and SHV gene, respectively. This study helps to assess/analyse the relation between
the spectrum of microorganisms present in various grades of faecal carriage and their susceptibility
pattern in this part of the Vellore town.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Antibacterial resistance has been recognized as an up-
and-coming worldwide problem in both human and animals,
and antibacterial agent use is considered the most important
factor for the emergence, selection, and dissemination of
antimicrobial agent-resistant bacteria (Prescott et al., 2000).
The principle behind the development of resistance is thatn faecal
2 S.R.E. Priyadharshini et al.bacteria in the guts of humans are subjected to different types,
concentrations, and frequencies of antimicrobial agents. Over
time, selective pressure selects resistant bacteria that have
specific fingerprints for resistance to the antimicrobial agents
that have been used. On other hand, contamination of the hos-
pital environment leads to the development of the antimicro-
bial agent resistance.
Worldwide, there are increasing problems with multiresis-
tant bacteria. The most important drug resistance today is
caused by methicillin-resistant Staphylococcus aureus (MRSA)
(Udo et al., 2001; Borg, 2003), vancomycin resistant entero-
cocci (VRE) (Calfee et al., 2003; Kuriyama et al., 2003) and
Enterobacteriaceae with extended-spectrum beta-lactamases
(ESBL). The common aerobic pathogens isolated from the
chronic wounds are S. aureus, coagulase negative Staphylococ-
cus (CONS), S. epidermidis and Streptococcus spp. Recent clin-
ical attention has focused on the increasing frequency of non-
lactose fermenting gram-negative pathogens responsible for
hospital-acquired infections, Pseudomonas aeruginosa and col-
iform bacteria (Armstrong et al., 1995). Multidrug resistant
organisms (MDROs) in the foot and hand ulcer infection
may increase the duration of hospital stay, an increase in cost
of management and might lead to additional morbidity and
mortality (Gadepalli et al., 2006). The first ESBL isolates were
discovered in Western Europe in the mid 1960’s. They were
found in a variety of Enterobacteriaceae spp. Most beta lacta-
mases function by a serine ester hydrolysis mechanism, render-
ing the antibiotics inactive. Beta-lactamases of gram negative
species are periplasmic and protect the cell (Thomson and
Sanders, 1992).
Resistance to broad-spectrum cephalosporins has emerged
in strains of members of the family Enterobacteriaceae follow-
ing frequent use of these drugs in the hospital setting. Endemic
and epidemic nosocomial infections caused by ESBL-
producing Escherichia coli and Klebsiella pneumoniae cells rep-
resent a persistent problem in many parts of the world
(Komatsu et al., 2003). Epidemic strains of cephalosporin-
resistant E. coli and K. pneumoniae have been associated with
increased morbidity and mortality in hospitalized patients.
Appropriate isolation measures need to be taken, hand hygiene
procedures may need reinforcement, possible environmental
reservoirs need elimination, and antibiotics policies may need
reconsideration (Gruteke et al., 2003; Muzaheed Doi et al.,
2008).
To test this hypothesis, the two objectives of this study were
(i) to identify patterns of antimicrobial agent resistance of bac-
terial strains obtained from the faecal carriage of in-patients of
Government Vellore Medical College and Hospital, Vellore (ii)
to subject Enterobacteriaceae and non-Enterobacteriaceae
bacteria to ESBL screening.2. Materials and methods
2.1. Sample collection
Specimens (faecal samples) for microbiological studies were
obtained from in-patients admitted in different wards of the
Government Vellore Medical College and Hospital
(GVMCH), Vellore. Faecal samples were collected in plastic
universal containers that were immediately put on ice. Clinical
details of the patients were also collected. The transport mediaPlease cite this article in press as: Priyadharshini, S.R.E. et al., Superintendence of
carriage in Vellore, India. Saudi Journal of Biological Sciences (2015), http://dx.doi(Muller Hinton broth) was used for specimen transport to our
laboratory.
2.2. Sample processing
A total of 187 faecal samples were collected. Direct examina-
tions of the specimen provided immediate semi-quantitative
information about the types of organisms present, and other
distinguishing characteristics of the specimens were also noted.
A direct smear was made from the specimen, and inocu-
lated into appropriate aerobic plating media, such as Blood
agar and MacConkey agar. The inoculated plates were imme-
diately incubated under aerobic condition at 37 C for 24 h,
respectively. The direct smear was dried, fixed, and gram
stained. The gram-stained smear was examined for informa-
tion about the types of organism present. The aerobic plates
were examined after 24 h of incubation. The isolated microor-
ganisms were identified using standard methods. Identification
of isolates were done based on colony morphology, gram
staining, motility, catalase test, oxidase test, coagulase test,
standard biochemical tests and oxidation-fermentation test
and other tests (Collee et al., 1996).
Each isolate was grown overnight (18–20 h) on Blood agar
or MacConkey agar. A single colony was made in the stock
medium i.e., 5% trypticase soy broth plus 20% v/v. All the iso-
lates were kept frozen at 70 C until further use.
2.3. Antimicrobial susceptibility test by disc diffusion method
All the isolates tested for antimicrobial susceptibility against
antimicrobial agents. Gram-positive bacteria were tested
against the various antibiotics such as ampicillin (A) – 10 lg,
chloramphenicol (C) – 30 lg, ciprofloxacin (Cf) – 5 lg, line-
zolid (Lz) – 10 lg, penicillin G (P) – 10 units, streptomycin
(S) – 10 lg, vancomycin (Va) – 30 lg, oxacillin (Oxa) –
30 lg, gentamycin (G) – 10 lg and co-trimoxazole (Co) –
25 lg disc. Gram-negative bacteria isolated from samples were
tested against various antibiotics such as amikacin (Ak) –
30 lg, ampicillin (A) – 10 lg, aztreonam (Ao) – 30 lg, cefe-
pime (Cpm) – 30 lg, ceftazidime (Ca) – 30 lg, cephotaxime
(Ce) – 30 lg, chloramphenicol (C) – 30 lg, ciprofloxacin (Cf)
– 5 lg, gentamycin (G) – 120 lg, imipenem (I) – 10 lg, nali-
dixic acid (Na) – 30 lg, norfloxacin (Nx) – 10 lg, tetracycline
(T) – 30 lg, trimethoprim (Tr) – 5 lg, ticarcillin (Tc) – 7.5 lg
and piperacillin/tazobactam (Pt) – 30 lg disc. S. aureus ATCC
25923, Enterococcus faecalis ATCC 29212, K. pneumoniae
ATCC 70063, P. aeruginosa ATCC 27853 and E. coli
ATCC11775 were used as control strains.
2.4. Antimicrobial susceptibility test by micro-broth dilution
method
The stock solution of oxacillin, cephotaxime, ceftazidime and
imipenem drugs were prepared dilution range of 1–64, 1–256,
1–256 and 1–256 respectively, according to the CLSI (2006)
recommendation. Inoculum of the test organisms were pre-
pared from colonies grown on Nutrient agar (Hi-media),
which had been incubated overnight (18–20 h) at 37 C in
the incubator. Colonies were suspended in Mueller Hinton
broth (Himedia) and adjusted to a turbidity of a 0.5 McFar-
land standard (1  108 CFU/ml).antimicrobial resistance observed in bacterial flora isolated from human faecal
.org/10.1016/j.sjbs.2015.11.008
Assortment of antimicrobial resistance observed in faecal bacteria 3Each well of the microtitre plate, containing 100 ll of the
respective antimicrobial solution followed was added with test
bacterial suspension (5 ll; 1  108 CFU/ml). The quality con-
trol strains, S. aureus ATCC 25923, E. faecalis ATCC29212,
K. pneumoniae ATCC70063 and P. aeruginosa ATCC 27853
were used in each run of daily testing. Each batch included a
growth control well (no antimicrobial agent) and a negative
control well (un-inoculated). After inoculation, each tray was
covered with a lid to prevent evaporation during incubation.
The micro dilution trays were incubated at 37 C for 16–20 h
in ambient incubator prior to reading. Care was taken to
ensure that no more than four trays were stacked in an array.
2.5. Phenotypic ESBL detection
The antimicrobial discs and combination discs (cephotaxime
30 lg, ceftazidime 30 lg, cefepime 30 lg, cephotaxime 30 lg/-
clavulanate 10 lg, ceftazidime 30 lg/clavulanate 10 lg and
cefepime 30 lg/clavulanate 10 lg) were placed on each plate;
the plates were incubated at 37 C and were incubated for
16–18 h. After incubation, each plate was examined. The diam-
eters of the inhibition zones were measured. An organism was
interpreted as the ESBL producer (positive) if there was an
increase of P5 mm in the inhibition zone of the combination
disc when compared to the corresponding cephalosporin disc
(CLSI, 2006).
2.6. Molecular detection of ESBL genes
b-lactamase genes (blaTEM, blaSHV, blaCTX-M) were
detected by polymerase chain reaction (PCR) using reverse
and forward primer pairs (Lim et al., 2009) with boiled suspen-
sion of bacterial cells, which were used as DNA template. All
the PCR mixes were made in sterile 0.2 ml PCR tubes and sub-
jected to thermal cycles created in the Eppendorf-Mastercycler
personnel PCR Machine.
2.7. Agarose gel electrophoresis
Agarose gel (1%) with ethidium bromide (50 lg/ml) was made
in 0.5 TAE buffer. A 10 ll of the PCR product mixed with
2 ll of gel loading dye and PCR products was resolved at
100 V for 20 min. 5 ll of 200 bp DNA ladder (Himedia) was
used to detect the size of the fragment in the gel. After the elec-
trophoresis was run, the gel was documented using Bio-rad gel
documentation system; the image was processed and repre-
sented in the results section.3. Results
3.1. Collection and processing of faecal samples
Totally 187 faecal samples were collected. Since 12 samples
were inadequate for further processing due to poor consistency
(i.e., too watery) or inadequate quantity and were not used in
the study, totally 175 samples were studied, 102 (58.28%) were
from men and 73 (41.71%) were from women. In this study it
was noted that single isolates were present in 62.5% of the col-
lected samples and multiple isolates were noted in 37.5% of the
collected samples.Please cite this article in press as: Priyadharshini, S.R.E. et al., Superintendence of
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Out of 296 isolates, 36 (12.16%) were gram positive organisms
and 260 (87.83%) were gram negative. A standard microbial
identification procedure (Collee et al., 1996) was used to
characterize the isolated bacterial strains and the results were
compared with Bergey’s manual of systematic bacteriology
and the identification chart was prepared for the isolates.
From the identification the following number of bacterial
isolate were obtained, Coagulase negative Staphylococcus –
07, S. aureus – 11, E. faecalis – 18, K. pneumonia – 15,
E. coli – 178, Citrobacter freundii – 26, Enterobacter aerogenes
– 19, Proteus mirabilis – 12 and P. aeruginosa – 10.
3.3. Antimicrobial sensitivity pattern by disc diffusion test
The results of the antimicrobial sensitivity pattern by disc dif-
fusion method for bacterial isolates are represented in Table 1.
Antibiotic sensitivity pattern of Staphylococcus spp. (includes
S. aureus (11) and CONS (7)) showed that oxacillin resistance,
i.e., methicillin resistant Staphylococcus (MRS), was 61.11%.
Almost all the strains were sensitive to linezolid, vancomycin,
gentamycin and chloramphenicol. Enterococci spp. showed
uniform susceptibility to vancomycin, linezolid and tetracy-
cline, which showed intermediate sensitivity to linezolid and
vancomycin by disc diffusion.
Enterobacteriaceae showed a wide range of resistance to
many of the drugs tested. Imipenem, cephotaxime, ceftazidime
and cefepime showed 12% (30/250), 56% (140/250), 48%
(120/250) and 68.8% (172/250) resistance, respectively.
Whereas, aztreonam, trimethoprim and tetracycline showing
a higher percentage of resistance 72%, 78.4% and 82%,
respectively, was observed.
Antibiotic sensitivity pattern of Non-Enterobacteriaceae
include P. aeruginosa (10). From 10 isolates of P. aeruginosa
tested the following resistant pattern was observed: cepho-
taxime 60% (6/10), ceftazidime 70% (7/10) and cefepime
50% (5/50). Whereas other beta-lactams like imipenem, aztre-
onam, ticarcillin and piperacillin/tazobactam showed resistant
patterns of 40% (4/10), 80% (8/10), 70% (7/10), and 90%
(9/10), respectively. Aminoglycosides like tobramycin and ami-
kacin showed 2/10 (20%) and 8/10 (80%) of resistance,
respectively.
3.4. MIC by micro-broth dilution method
The micro-broth dilution method was done for gram positive
(oxacillin) and gram negative (i.e., cephotaxime, ceftazidime
and Imipenem) bacterial pathogen; the results are shown in
Table 2. Dilution ranges of 1 to >32 lg/ml for oxacillin and
1–256 lg/ml for cephotaxime, ceftazidime and imipenem were
used. According to the micro-broth dilution method, 9.09%
(1/11) of MSSA and 90.90% (10/11) are MRSA. This is com-
paratively much higher than coagulase negative staphylococci
which showed 57.14% (4/7) resistance and 42.85% (3/7) sensi-
tivity to methicillin.
From 250 Enterobacteriaceae isolates, 40% (100/250),
11.6% (29/250) and 48.4% (121/250) were susceptible, inter-
mediately resistant and resistant to cephotaxime, respectively.
For ceftazidime, 14% (35/250), 10% (25/250) and 76%
(190/250) were susceptible, intermediately resistant and resis-antimicrobial resistance observed in bacterial flora isolated from human faecal
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Table 1 Antibiotic resistance pattern by disc diffusion method.
Antibiotic Staphylococcus spp.
(n= 18)
Enterococcus faecalis
(n = 18)
Enterobacteriaceae
(n= 250)
Pseudomonas aeruginosa
(n= 10)
R (%) I (%) S (%) R (%) I (%) S (%) R (%) I (%) S (%) R (%) I (%) S (%)
Oxacillin 61.11 11.11 27.77 – – – – – – – – –
Vancomycin 0 0 100 0 0 100 – – – – – –
Gentamycin 44.4 5.55 49.99 16.6 16.6 66.6 52 8 40 – – –
Ciprofloxacin 33.3 38.85 27.75 0 27.7 72.2 48 44 8 30 20 50
Erythromycin 11.11 55.5 33.33 – – – – – – – – –
Chloramphenicol 22.22 11.11 66.66 0 66.6 33.3 – – – – – –
Co-trimoxazole 8.85 11.11 38.85 – – – – – – – – –
Tetracycline 27.75 38.85 33.33 0 22.2 77.7 82 6 8 – – –
Linezolid 0 0 100 0 0 100 – – – – – –
Clindamycin 44.44 5.55 49.99 – – – – – – – – –
Streptomycin – – – 27.7 27.7 44.4 – – – – – –
Penicillin – – – 50 27.7 22.2 – – – – – –
Ampicillin – – – 33.3 0 66.6 58.4 4 38.4 – – –
Cefepime – – – – – – 68.8 11.2 20 50 20 30
Cephotaxime – – – – – – 56 24 20 60 10 30
Ceftazidime – – – – – – 48 22.4 29.6 70 20 10
Imipenem – – – – – – 12 16 72 40 20 40
Trimethoprim – – – – – – 78.4 8 10.4 – – –
Aztreonam – – – – – – 72 8 20 – – –
Amoxicillin – – – – – – 44 12 44 – – –
Tobramycin – – – – – – – – – 20 10 70
Piperacillin/tazobactam – – – – – – – – – 90 10 0
Amikacin – – – – – – – – – 80 0 20
Ticarcillin – – – – – – – – – 70 20 10
Aztreonam – – – – – – – – – 90 0 10
Table 2 Minimal inhibitory concentration by micro-broth dilution method.
S. no Drug concentration (lg/ml) P. aeruginosa Enterobacteriaceae^ S. aureus CONS
CTX CAZ I CTX CAZ I Oxa Oxa
1 256 4 3 2 70 84 6 – –
2 128 2 1 1 40 76 0 – –
3 64 0 4 0 11 0 0 – –
4 32 0 0 0 09 30 62 3 0
5 16 1 1 2 20 25 48 1 0
6 8 1 0 2 60 15 68 4 1
7 4 0 1 1 25 20 26 2 3
8 2 1 0 2 5 0 40 1 2
9 1 1 0 0 10 0 0 0 1
Total 10 10 10 250 250 250 11 07
CTX – cephotaxime, CAZ – ceftazidime, I – imipenem, Oxa – oxacillin, Enterobacteriaceae^-include E. coli, P. mirabilis, K. pneumoniae, E.
aerogenes, and C. freundii.
4 S.R.E. Priyadharshini et al.tant, respectively. For imipenem, 26.4% (66/250), 27.2%
(68/250) and 46.4% (116/25) were susceptible, intermediately
resistant and resistant, respectively. Comparisons of MIC
and disc diffusion method for antibiotic sensitivity of Enter-
obacteriaceae against 3 drugs cephotaxime, ceftazidime and
imipenem were carried out. Totally, 121 out of 250 resistant
in MIC and 29/250 isolates showed intermediately resistant
in MIC among these 140/250 resistant, 60/250 intermediate
resistant and 50/25 were sensitive in disc diffusion method ofPlease cite this article in press as: Priyadharshini, S.R.E. et al., Superintendence of
carriage in Vellore, India. Saudi Journal of Biological Sciences (2015), http://dx.doicephotaxime. The second drug ceftazidime MIC showed an
increased number of resistant isolates (190/250) compared to
disc diffusion results (120/25). In the third antibiotic imipe-
nem, 116 out of 250 were resistant in MIC and 30/250 resistant
in disc diffusion.
In P. aeruginosa, 60% (6/10) of the isolates tested were
resistant, 10% (1/10) isolates were intermediately resistant
and 30% (3/10) isolates were sensitive to cephotaxime, 80%
(8/10) isolates were resistant, 10% (1/10) were intermediatelyantimicrobial resistance observed in bacterial flora isolated from human faecal
.org/10.1016/j.sjbs.2015.11.008
Table 3 Phenotypic extended-spectrum beta-lactamase screening for gram-negative bacteria.
Gram negative bacteria Isolates (n) Cephotaxime + clavulanic acid Ceftazidime + clavulanic acid Cefepime + clavulanic acid
P N P N P N
Enterobacteriaceae 250 97 153 72 178 58 192
Pseudomonas aeruginosa 10 6 4 6 4 3 7
Total 260 103 157 78 182 61 199
P – positive, N – negative, Enterobacteriaceae^-include E. coli, P. mirabilis, K. pneumoniae, E. aerogenes and C. freundii.
Assortment of antimicrobial resistance observed in faecal bacteria 5resistant while remaining isolates 10% (1/10) were sensitive to
ceftazidime. In case of imipenem, 5/10 isolates tested was resis-
tant, another 2/10 isolates were intermediately resistant, while
3/10 isolates were found to be sensitive. Totally, 220/296
(74.32%) multidrug resistance isolates found out of 275 speci-
mens were found in this study, including both gram-positive
and gram-negative pathogens.
3.5. Phenotypic extended-spectrum beta-lactamase screening for
gram-negative bacterial isolates
In the present study, all 260 gram-negative isolates were sub-
jected to ESBL screening using a single disc synergy test
(Table 3). The antibiotic combination of cephotaxime
+ clavulanate, ceftazidime + clavulanate and cefepime
+ clavulanate showed ESBL positivity of 103/260, 78/260
and 61/260, respectively. Although in in vitro tests, ESBLs
are inhibited by beta-lactamase inhibitors such as clavulanic
acid, the activity of beta-lactam/beta-lactamase inhibitor com-
bination agents was influenced by the bacterial inoculum, dose
administration regimen and specific type of ESBL present.
3.6. Genotypic extended-spectrum beta-lactamase screening for
gram-negative bacterial isolates
Today over 150 different ESBLs have been described. Most of
them are derivatives of TEM or SHV or CTX-M enzymes.
There are now more than 90 TEM type b lactamases and more
than 25 SHV type enzymes described.
3.7. CTX-M
In recent years a new family of plasmid mediated ESBLs called
CTX-M that preferentially hydrolyze cefotaxime has arisen. In
this study, ESBL gene detection by PCR using universal pri-
mers showed that out of 260 isolates, Enterobacteriaceae
tested positive for 86 isolates and 3 P. aeruginosa isolates were
found to be positive for CTX-M gene (Amplicon size is 593 bp;
Fig. 1). The preponderance of CTX-M type ESBLs was found
in strains of E. coli (69/178) and K. pneumoniae (7/15)
(Table 4).
3.8. TEM
In this study, likewise when the same set of isolates were sub-
jected to TEM gene detection Enterobacteriaceae showed
82/250 positive for TEM and 4/10 isolates of P. aeruginosa
were found to be positive for the TEM gene (Amplicon size:
867 bp; Fig. 2). The greater part of TEM type ESBLs is foundPlease cite this article in press as: Priyadharshini, S.R.E. et al., Superintendence of
carriage in Vellore, India. Saudi Journal of Biological Sciences (2015), http://dx.doiin strains of E. coli (71/178) and P. aeruginosa (4/10) and fol-
lowed by P. mirabilis (3/12) (Table 4).
3.9. SHV
In this study, SHV 94/250 and 4/10 SHV isolates were positive
for Enterobacteriaceae and P. aeruginosa, respectively (Fig. 3).
The majority of SHV type ESBLs was found in strains of
E. coli (66/178). However, these enzymes have also been found
in K. pneumonia, P. mirabilis and P. aeruginosa. Several organ-
isms yielded more than one ESBL gene which is compared in
Table 4.4. Discussion
Worldwide, there are increasing problems with multi-resistant
bacteria. The development of resistance is that bacteria in the
guts of humans are subjected to different types, concentra-
tions, and frequencies of antimicrobial agents. Poly-microbial
nature of faecal samples was observed, 175 faecal samples in
triplicate were analysed and 296 bacterial pathogens were iso-
lated. S. aureus is an important cause of healthcare associated
infections (Lowy, 1998). The mechanism by which intestinal
colonization by S. aureus might lead to an increased risk of
staphylococcal infections is not known. Squier et al. (2002)
indicate that intestinal colonization by S. aureus could be asso-
ciated with increased frequency of colonization or contamina-
tion of skin sites, thereby increasing the risk for contamination
of devices, wounds, and mucous membranes. Though it was
observed to have a higher percentage of MRSA in this study,
the isolates were uniformly susceptible to vancomycin, the inci-
dence of vancomycin-intermediate S. aureus (VISA) and
vancomycin-resistant S. aureus (VRSA) has been increasing
in various parts of the world. The first clinical isolate of VRSA
reported from the United States in 2002 (CDC, 2002).
E. faecalis was the common isolate than E. faecium as seen
in all other clinical specimens. A faecal indicator bacterium
with a host range limited to humans and a few other warm-
blooded animal species would also simplify microbial source
tracking because only a few animal species would be required
for any host origin database. All the strains showed intermedi-
ate sensitivity to linezolid and vancomycin by disc diffusion,
the result is similar to that of studies reported by
Abdulrazak et al. (2005). E. faecalis is the most prevalent spe-
cies cultured from humans, accounting for more than 90% of
clinical isolates (De Perio et al., 2006).
Enterobacteria in faecal flora are often reported to be highly
resistant. E. coli are the main species; resistance data on other
species are rare. Gram negative organisms showed a variedantimicrobial resistance observed in bacterial flora isolated from human faecal
.org/10.1016/j.sjbs.2015.11.008
Figure 1 Agarose gel showing products of CTX-M PCR amplification.
Table 4 Genotypic ESBL screening for gram-negative bacteria.
Gram negative bacteria Isolates (n) CTXM TEM SHV CTXM+ TEM CTXM+ SHV TEM+ SHV
P N P N P N P N P N P N
Enterobacteriaceae^ 250 86 164 82 168 94 156 42 208 57 193 66 184
Pseudomonas aeruginosa 10 3 7 4 6 4 6 2 8 1 9 1 9
Total 260 89 171 86 174 98 162 46 216 58 202 67 193
P – positive, N – negative, Enterobacteriaceae^-include E. coli, P. mirabilis, K. pneumoniae, E. aerogenes and C. freundii.
6 S.R.E. Priyadharshini et al.pattern of resistance to the disc diffusion method. Gadepalli
et al. (2006) showed a different pattern for P. aeruginosa where
both cephotaxime and ceftazidime having same resistance of
61.1%, piperacillin/tazobactam (72.2%). Whereas, this study
found different resistance pattern of cephotaxime and
ceftazidime showing 60% and 70%, respectively. The
piperacillin/tazobactam showed 100% resistance patternPlease cite this article in press as: Priyadharshini, S.R.E. et al., Superintendence of
carriage in Vellore, India. Saudi Journal of Biological Sciences (2015), http://dx.doialmost in concordance with that of showing resistant pattern
of (90%). Apart from these various resistant patterns towards
commonly used antibiotics a different observation was reported
by Bansal et al. (2008) showing sensitivity to amikacin, cef-
tazidime and piperacillin. In MIC analysis showing the resis-
tance pattern of the isolates, it was found that Pseudomonas
which is the commonest isolate, was highly resistant toantimicrobial resistance observed in bacterial flora isolated from human faecal
.org/10.1016/j.sjbs.2015.11.008
Figure 2 Agarose gel showing products of TEM PCR amplification.
Assortment of antimicrobial resistance observed in faecal bacteria 7ceftazidime (80%) followed by cefotaxime. This is in contrast,
however, to some other study which reported that Pseudomonas
was highly sensitive to ceftazidime (Revathi et al., 1998).
The erosion of effective antimicrobials continues as wit-
nessed increased frequency of resistance to all drugs in partic-
ular, the fluoroquinolones, vancomycin and carbapenems,
which are often the drugs of last choice. New drugs that can
combat multiple drug resistant gram-positive bacteria have
averted forthcoming crises. With the relative absence of new
antimicrobials coming to market and with new threats arising
from the gram-negative bacteria, however, the number of drug
options leaves us perilously close to none or only a single effec-
tive agent for some life-threatening infections. Hundreds of
beta-lactam-degrading enzymes are rapidly undermining the
mainstay penicillins and late generation cephalosporin agents.
The increase in metallo-beta-lactamases, which are active
against carbapenems and most other beta-lactams, is an alarm-
ing new development (Livermore and Woodford, 2000).Please cite this article in press as: Priyadharshini, S.R.E. et al., Superintendence of
carriage in Vellore, India. Saudi Journal of Biological Sciences (2015), http://dx.doiWith the emergence of antimicrobial resistance in bacteria
as a global problem, national and international surveillance
programmes have been developed to monitor resistance
(Felmingham and Gruneberg, 1996; Pfaller et al., 1997;
Turner et al., 1999; Jones and Masterton, 2001; Felmingham,
2002). The emergence of plasmid mediated extended spectrum
b-lactamases (ESBLs) in members of family Enterobacteri-
aceae has become a worldwide problem (Paterson and
Bonomo, 2005). Many clinical microbiology laboratories make
no effort to detect ESBL production by gram negative bacilli
and have a problem in detecting ESBL mediated resistance.
A few point mutations at selected loci within the gene give rise
to extended spectrum phenotype (Levison et al., 2002; Cagatay
et al., 2003; Komatsu et al., 2003). These enzymes are not very
closely related to TEM or SHV b lactamases and exhibit
approximately 40% identity with these two commonly isolated
b lactamases (Glupczynski et al., 2007; Kim et al., 2007;
Muzaheed Doi et al., 2008).antimicrobial resistance observed in bacterial flora isolated from human faecal
.org/10.1016/j.sjbs.2015.11.008
Figure 3 Agarose gel showing products of SHV PCR amplification.
8 S.R.E. Priyadharshini et al.TEM-1 is the most commonly encountered b lactamases in
gram negative bacteria. Up to 90% of ampicillin resistance in
E. coli is due to the production of TEM-1. This enzyme is also
responsible for ampicillin and penicillin resistance. TEM-1 is
able to hydrolyze penicillins and early cephalosporins such as
cephalothin and cephaloridine. TEM-2, the first derivative of
TEM-1, has a single aminoacid substitution from the original
b lactamase. TEM-3 originally reported in 1989, was the first
TEM type b-lactamase that displayed the ESBL phenotype.
In the years since that first report, over 90 additional TEM
derivatives have been described. Some of these b lactamases
are inhibitor resistant enzymes, but the majority of the new
derivatives are ESBLs (Vourli et al., 2004; Glupczynski
et al., 2007).
The SHV-1 b lactamase is most commonly found in K.
pneumonia and E. coli and is responsible for up to 20% of plas-
mid mediated ampicillin resistance. Unlike the TEM type b
lactamase, there are relatively a few derivatives of SHV-1. Fur-
thermore, the changes that have been observed in blaSHV toPlease cite this article in press as: Priyadharshini, S.R.E. et al., Superintendence of
carriage in Vellore, India. Saudi Journal of Biological Sciences (2015), http://dx.doigive rise to the SHV variants occur in fewer positions within
the structural gene. The majority of SHV variants possessing
an ESBL phenotype were characterized by the substitution
of lysine for glutamate at position 238 (Levison et al., 2002;
Paterson and Bonomo, 2005). This study helps to assess/anal-
yse the relation between the spectrum of microorganisms pre-
sent in various grades of faecal samples and their susceptibility
pattern in this part of the Vellore town.
5. Conclusions
Out of 296 isolates, 36 (12.16%) were gram positive organisms
and 260 (87.83%) were gram negative. The antimicrobial sen-
sitivity pattern by disc diffusion method and the antimicrobial
sensitivity pattern by disc diffusion method were performed.
Phenotypic extended-spectrum beta-lactamase screening for
gram-negative bacterial isolates was studied. The antibiotic
combination of cephotaxime + clavulanate, ceftazidime
+ clavulanate and cefepime + clavulanate showed ESBL pos-antimicrobial resistance observed in bacterial flora isolated from human faecal
.org/10.1016/j.sjbs.2015.11.008
Assortment of antimicrobial resistance observed in faecal bacteria 9itivity of 103/260, 78/260 and 61/260, respectively. Although in
in vitro tests, ESBLs are inhibited by beta-lactamase inhibitors
such as clavulanic acid, the activity of beta-lactam/
beta-lactamase inhibitor combination agents was influenced
by the bacterial inoculum, dose administration regimen and
specific type of ESBL present. Genotypic extended-spectrum
beta-lactamase screening for gram-negative bacterial isolates
was confirmed by TEM or SHV or CTX-M enzymes. The pre-
ponderance of CTX-M type ESBLs was found in strains of
E. coli (69/178) and K. pneumoniae (7/15). The greater part
of TEM type ESBLs is found in strains of E. coli (71/178)
and P. aeruginosa (4/10) and followed by P. mirabilis (3/12).
The majority of SHV type ESBLs was found in strains of
E. coli (66/178).
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